By Jaime Llinares Taboada

 

AstraZeneca PLC said Tuesday that it will invest $360 million in a manufacturing facility in Ireland.

The pharmaceutical company said it is planning to build an active pharmaceutical ingredient-manufacturing facility for small molecules near Dublin to ensure that its supply network is fit for future growth.

The plant will allow for late-stage development and early commercial supply, AstraZeneca said. It will create 100 direct jobs and further indirect jobs.

 

Write to Jaime Llinares Taboada at jaime.llinares@wsj.com; @JaimeLlinaresT

 

(END) Dow Jones Newswires

September 21, 2021 02:23 ET (06:23 GMT)

Copyright (c) 2021 Dow Jones & Company, Inc.
Astrazeneca (LSE:AZN)
Historical Stock Chart
From Nov 2021 to Dec 2021 Click Here for more Astrazeneca Charts.
Astrazeneca (LSE:AZN)
Historical Stock Chart
From Dec 2020 to Dec 2021 Click Here for more Astrazeneca Charts.